Yoga effects on cardiovascular health in patients with acute heart attack

Effect of Yoga based Cardiac Rehabilitation Program on Vascular Endothelial function in Patients with Acute Myocardial Infarction: A mechanistic sub-study of Yoga CaRe Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012801

Enrollment

Registered

2018-03-23

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Acute Myocardial Infarction Health Condition 2: I219- Acute myocardial infarction, unspecified

Interventions

Intervention1: Yoga based Cardiac Rehabilitation program: The intervention arm subjects will be given yoga based Cardiac rehabilitation as an adjunct to standard care for three months. Each session wi

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with acute myocardial infarction within duration of one month. Myocardial infarction as confirmed by standard definition (symptoms, Troponin and electrocardiographic changes). Those who have undergone a revascularisation procedure during previous or current admission will also be eligible. Patients referred from other hospitals and admitted in the clinical site for diagnostic or therapeutic reasons within 7 days of the acute myocardial infarction are also eligible for participation. 2. Patients willing and able to attend the complete hospital-based Yoga Cardiac Rehabilitation programme.

Exclusion criteria

Exclusion criteria: Patients will be considered ineligible if they have any of the following during screening 1. Patients who will not be able to complete the study duration and/or cannot come for the follow-up. 2. Participants who regularly practice yoga i.e., participants who practice more than 3 hours of yoga a week. 3. Any other diseases which limits the life years less than one year such as severe valvular diseases, recurrent ventricular arrhythmias, heart failure (Killip class IV), cancers, severe aortic incompetence, severe atrial fibrillation, end stage renal diseases and end stage liver diseases.

Design outcomes

Primary

Measure	Time frame
Changes in endothelial functionTimepoint: Three months	—

Secondary

Measure	Time frame
Changes in arterial stiffness, oxidative stress and inflammationTimepoint: Three months	—

Countries

India

Contacts

Public ContactDr Satish G Patil

Shri B.M.Patil Medical College Hospital and Research Centre BLDE (Deemed University)

sathupatil@yahoo.co.in9986789583

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026